Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
Yokoyama M, Chiba T, Zen Y, Oshima M, Kusakabe Y, Noguchi Y, Yuki K, Koide S, Tara S, Saraya A, Aoyama K, Mimura N, Miyagi S, Inoue M, Wakamatsu T, Saito T, Ogasawara S, Suzuki E, Ooka Y, Tawada A, Otsuka M, Miyazaki M, Yokosuka O, Iwama A.
Yokoyama M, et al. Among authors: inoue m.
Oncotarget. 2017 Mar 28;8(13):21315-21326. doi: 10.18632/oncotarget.15528.
Oncotarget. 2017.
PMID: 28423509
Free PMC article.